Purpose: To study whether the glistening on implanted acrylic intracular lenses increases or not.
Method: 1. Prospective study: We studied the glistening on 49 implanted acrylic intraocular lenses, particularly the time of appearance and increase after glistening appeared. 2.
Experiment: We kept an intraocular lens immersed in saline solution at 50 degrees centigrade for two hours and then moved this lens into saline solution at 35 degrees centigrade, and observed this lens during immersion.
Results: 1. Prospective study: Glistening was present in 28 eyes (57%), and appeared from 2 to 16 months postoperatively. A few months after appearance it become stable and did not increase further. 2.
Experiment: On the 10th day after observation, we could see glistening on the lenses. The points of glistening were 10 microns or less in size, and did not change during 60 days of observation.
Conclusion: The glistening in acrylic intraocular lenses seemed to become stable a few months after appearance. This our experimental method is useful, because it gives us glistening similar to clinical cases in a short time.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Visual Outcomes and Quality of Vision After Bilateral Implantation of a Hydrophobic Acrylic Trifocal Intraocular Lens.
Clin Ophthalmol
January 2025
Sengi, Penniac, NB, Canada.
Purpose: To evaluate visual outcomes and quality of vision following bilateral implantation of a hydrophobic acrylic intraocular lens (IOL) in eyes targeted for emmetropia.
Methods: This was a prospective, single arm study. Subjects were bilaterally implanted with the Clareon PanOptix IOL and evaluated at 1 and 3 months postoperatively.
Visual Performance After Bilateral Implantation of a New Enhanced Monofocal Hydrophobic Acrylic Intraocular Lens Targeted for Mini-Monovision.
Life (Basel)
January 2025
Centro Oftalmológico Charles, Buenos Aiers C1116, Argentina.
Background: The aim of this study was to evaluate visual outcomes and patient satisfaction after bilateral implantation of a new hydrophobic acrylic intraocular lens called Clareon (Alcon) using the mini-monovision technique.
Methods: A single-center, prospective, nonrandomized study was conducted in Tandil (Buenos Aires, Argentina), including patients scheduled for cataract surgery. To achieve mini-monovision, the spherical equivalent was calculated between -0.
Clinical Features, Risk Factors and Outcomes following Surgery for Late Intraocular Lens Decentration in the Dead Bag Syndrome.
Am J Ophthalmol
January 2025
Raghudeep Eye Hospital, Laden Cataract and IOL research centre, Ahmedabad, India 380052.
Purpose: To evaluate demographic profile, risk factors and outcomes following intraocular lens (IOL) exchange surgery for late decentration of IOLs in the dead bag syndrome DESIGN: Prospective, interventional case series PARTICIPANTS: 46 eyes (43 patients) with late decentration/dislocation of IOLs and spontaneous posterior capsule rupture in a clear and relatively intact capsular bag. None of the eyes had significant zonular weakness.
Methods: Study conducted at Raghudeep Eye Hospital, India.
Influence of Lens Power on IOL/Posterior Lens Capsule Interactions and IOL's PCO Potential.
Invest Ophthalmol Vis Sci
January 2025
Department of Bioengineering, University of Texas at Arlington, Arlington, Texas, United States.
Purpose: Severely myopic eyes have been associated with high posterior capsule opacification (PCO) incidence. Although it has been reported that myopic eyes have weaker or more delayed capsule adhesion than emmetropic eyes, it is unclear whether/how dioptric power and posterior curvature of IOLs affect IOLs' affinity for the posterior lens capsule (PLC) and their PCO potential.
Methods: To investigate this, acrylic foldable IOLs with increasing dioptric power of 6.
Visual and Refractive Outcomes After Bilateral Implantation of a New Toric Intraocular Lens.
Clin Ophthalmol
December 2024
The Department of Ophthalmology, The Shammas Eye Medical Center, Lynwood, CA, USA.
Purpose: To evaluate the clinical outcomes of a new FDA approved toric aspheric hydrophobic acrylic intraocular lens.
Patients And Methods: This is a single surgeon, single-arm, on-label, non-randomized, prospective observational study. Thirty patients underwent bilateral cataract surgery (60 eyes) with placement of a Clareon™ Toric IOL in each eye.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!